During the past decade, Clin Pharm International GmbH, Zentrum Wien conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Clin Pharm International GmbH, Zentrum Wien" are "Subjective Tinnitus" (2 trials). Many other conditions were trialed in "Clin Pharm International GmbH, Zentrum Wien" in a lesser frequency.

Most popular intervention types in "Clin Pharm International GmbH, Zentrum Wien" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Neramexane mesylate" (2 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clin Pharm International GmbH, Zentrum Wien" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Clin Pharm International GmbH, Zentrum Wien". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Clin Pharm International GmbH, Zentrum Wien, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Clin Pharm International GmbH, Zentrum Wien, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".